Day One Biopharmaceuticals, Inc. - Common Stock (DAWN)

Day One Biopharmaceuticals Inc is a biotechnology company focused on developing innovative therapies for patients with serious diseases, particularly in the field of oncology

The company is dedicated to creating targeted treatments for pediatric and adult patients, with an emphasis on precision medicine that addresses the specific genetic and molecular characteristics of their cancers. By leveraging advanced science and a deep understanding of cancer biology, Day One aims to deliver effective, safe, and impactful therapeutic options, improving the lives of patients facing difficult-to-treat conditions.